Ca2+/Calmodulin-Dependent Protein Kinase II-Dependent Regulation of TREK-1 by Whipple, Michael
 
 
 
 
 
 
Ca2+/Calmodulin-Dependent Protein Kinase II-Dependent 
Regulation of TREK-1 
 
Michael L. Whipple II 
The Dorothy M. Davis Heart and Lung Research Institute, 
Department of Biomedical Engineering, The Ohio State University 
 
 
 
 
Honors Thesis 
 
 
 
Presented in the Partial Fulfillment of the Requirements for the Degree Bachelor 
of Science in Biomedical Engineering with Honors Research Distinction of  
The Ohio State University 
 
 
 
The Ohio State University 
2014 
 
 
 
 
 
Thesis Committee: 
Dr. Thomas Hund 
Dr. Peter Mohler 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright by 
Michael Whipple II 
2014 
 
 
 
 
 
 
 
 
 
 
 
 
 
ii 
 
Abstract 
Ion channels serve as core constituents of macromolecular complexes that regulate cell 
membrane excitability and cell signaling pathways. Thus, proper ion channel function is essential 
for heart function. Importantly, ion channel activity is heavily regulated by posttranslational 
modifications. The mechano-sensitive two pore K+ channel TREK-1 has been identified as an 
important channel for proper repolarization in the heart and has been shown to induce actin 
reorganization resulting in filopodia-like protrusions in COS M6 cells. Ca2+/calmodulin-dependent 
protein kinase II (CaMKII), an important multifunctional serine/threonine kinase that has been 
linked to cardiac diseases such as hypertrophy, arrhythmias, and cardiac failure, has been 
identified as a potential regulator of TREK-1 activity. However, little is known about the mechanism 
and/or role of CaMKII-dependent regulation of TREK-1. We created a library of TREK-1 mutants 
using site-directed mutagenesis to ablate putative CaMKII phosphorylation sites located in the 
intracellular domains of the channel.  Wildtype (WT) and mutant TREK-1 constructs were 
engineered into a GFP-expressing pIRES vector and expressed in COS M6 cells. Cells were 
immunostained with TREK-1 antibody and the cell shape, size, and structure were analyzed using 
confocal microscopy. In parallel, TREK-1 fragments corresponding to the major intracellular 
domains (N-terminal, linker, and C-terminal) were generated as GST fusion proteins and used for 
in vitro CaMKII phosphorylation assays.  Our studies indicate that CaMKII phosphorylates TREK-1 
at a site in the N-terminal intracellular domain.  Cells expressing the TREK-1 N-terminal mutant 
(Ser46Ala) showed little difference in cytoskeletal organization compared to WT-expressing cells. 
However, these cells were significantly smaller than both untransfected and WT cells.  These 
studies suggest that CaMKII phosphorylates TREK-1 at a site in the N-terminus and that although 
this site may not play a significant role in the formation of membrane protrusions, this site may be 
part of cell signaling pathways that affect cell size. Future studies will determine whether CaMKII 
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targets additional sites on the channel and whether CaMKII-dependent phosphorylation of TREK-1 
is important for regulating other cell functions. 
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1. Introduction 
 
1.1 Background Information 
Proper ion channel function is essential to human health. Ion channels serve as 
core constituents of well-defined macromolecular complexes that regulate cell 
membrane excitability and cell signaling pathways. Importantly, ion channels are heavily 
regulated by posttranslational modification (e.g. phosphorylation, oxidation), which can 
have a wide array of effects on how ion channels behave.  
One important ion channel that has been increasingly studied due to its 
importance in excitable cells is the K2P channel TREK-1 (Figure 1).1,2 The TREK-1 
channel is expressed in the brain,3,4,5 dorsal root ganglia,6,7 smooth muscles surrounding 
the prostate and gastrointestinal tract,4,5 cardiovascular system,8,9 and myocardium.10,11 
TREK-1 is an important channel due to its role in the biological response to anesthesia,12 
neuroprotection,13 sensitivity to pain and temperature,6,7 depression,14 epilepsy,15 and 
architecture of the anterior eye chamber.16 At the cellular level, membrane excitability is 
regulated by TREK-1 and has been shown to be important for proper membrane 
repolarization. In cardiomyocytes, it has been shown that TREK-1 is part of a 
macromolecular complex with the actin-associated polypeptide βIV-spectrin, which 
regulates TREK-1 localization to the plasma membrane (Figure 2). Localization due to 
βIV-spectrin is essential for proper channel activity and repolarization.11 TREK-1 activity 
is also dependent upon a large range of chemical and physical stimuli and is activated 
by mechanical stretching,17 intracellular acidosis,18 increased temperature,19 
polyunsaturated fatty acids,13 and volatile and gaseous anesthesia.20  
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In addition to its roles in membrane excitability, TREK-1 has been linked to 
cytoskeletal restructuring through its interaction with actin.21 Actin is an essential 
structural protein that can be present as both a free monomer in the form of G-actin and 
a linear polymer microfilament called F-actin. This protein is generally the most abundant 
protein in eukaryotic cells and is important for cell motility, maintenance of cell shape 
and size, mechanical properties of the cell, cellular signaling pathways, protein 
localization, and other essential cell functions.22 Inhibition of TREK-1 expression has 
been shown to reduce F-actin and increase deformability in alveolar epithelial cells.23 
Additionally, TREK-1 expression has been linked to the production of actin-filled 
filopodia-like structures.21 Although there is strong evidence that TREK-1 expression 
regulates cytoskeletal restructuring by altering actin, the mechanism behind this is not 
well understood. Additionally, much is still unknown as to how this altered actin 
patterning affects cell size, structure, mechanical properties, excitability, and function. 
Figure 1:  TREK-1 structure with putative CaMKII phosphorylation sites 
(Arg-x-x-Ser/Thr) in the intracellular domains of TREK-1 indicated by 
red dots. 
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Posttranslational modification of TREK-1 has been shown to be extremely 
important for regulating its role in membrane excitability and cytoskeletal reorganization. 
TREK-1 has two important phosphorylation sites at Ser311 and Ser344 (human TREK-
1). Activation of protein kinase A (PKA) and protein kinase C (PKC) via a G-coupled 
protein channel signaling pathway leads to phosphorylation of S344 and S311 
sequentially to inhibit ionic current through TREK-1.24 In addition to regulating the 
channel conductance, S344 regulates signaling between TREK-1 and actin altering the 
cytoskeleton of the cells. Phosphorylation of TREK-1 at this amino acid highly increases 
the percentage of cells exhibiting filopodia-like protrusions.21 Although phosphorylation 
at these sites have been studied, other potential phosphorylation sites of TREK-1 and 
their effects on cell excitability and cytoskeletal reorganization remain unknown.  
An important protein that regulates a variety of intracellular proteins via 
phosphorylation is Ca2+/calmodulin-dependent protein kinase II (CaMKII). CaMKII is a 
multifunctional serine/threonine kinase that has four different isoforms that show varied 
tissue distribution. CaMKII regulates a wide array of cellular functions including ion 
channel activity,25,26 organelle transport,27 metabolism,28 transcription,29 and cytoskeletal 
structure.30 Hormone secretion,31 cardiac excitation-contraction coupling,26 and synaptic 
plasticity32 are all modulated by CaMKII and abnormal CaMKII behavior has been linked 
to cardiac arrhythmias,33 hypertrophy,34,35,36 heart failure,34,37 and cognitive defects.38   
Activity of CaMKII depends upon intracellular Ca2+ binding to calmodulin which in 
turn binds to and inhibits the regulatory domain of CaMKII.39 Posttranslational 
modification of CaMKII by autophosphorylation of Thr287,40 oxidation of Met281/282,41 
O-linked glycosylation of Ser280,42 or NO-dependent nitrosylation of Cys116, Cys273, or 
Cys290 also induce CaMKII activity,43 while phosphorylation of Thr306/307 reduce 
CaMKII activity.40  Due to these posttranslational modifications, CaMKII activity is usually 
upregulated during stress in tissues which has been linked to different pathologies.4235,42  
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Like TREK-1, CaMKII is a part of a macromolecular complex with βIV-spectrin 
(Figure 2). Previous studies have shown that the CaMKII/βIV-spectrin signaling complex 
is essential for membrane excitability. ΒIV-spectrin targets CaMKII to membrane proteins 
at the intercalcated disc in cardiomyocytes and the axon initial segment (AIS) in neurons 
for regulation. Phosphorylation of Nav1.5 by CaMKII is critical for proper heart function.44 
However, little is still known about this signaling complex and how it affects other 
membrane proteins and cell characteristics, like cell structure. 
 
 
 
 
 
 
1.2 Objectives 
 Our overall objective is to understand the pathways regulating electrical and 
structural remodeling of the myocardium in response to stress. The main objective of this 
study was to determine the molecular mechanism underlying TREK-1-dependent 
regulation of cellular remodeling. We hypothesize that CaMKII dependent 
phosphorylation of TREK-1 regulates channel activity and/or cytoskeletal restructuring. 
In order to increase our understanding of the roles of TREK-1 and CaMKII in cytoskeletal 
restructuring, the following two aims were investigated. 
 
Figure 2:  Structure of βIV-spectrin, its major binding partners, and two 
mutant mice strains that exhibit truncation of βIV-spectrin. 
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Specific Aim 1: Determine the mechanism of CaMKII phosphorylation of TREK-1. 
 We hypothesized that CaMKII directly phosphorylates TREK-1 to regulate its 
activity. In order to determine the site of phosphorylation of TREK-1 by CaMKII, a 
phosphorylation assay was carried out with CaMKII and the three intracellular domains 
of TREK-1 which were generated as GST-fusion proteins.  
 
Specific Aim 2: Determine the effects of phosphorylation at the putative CaMKII 
phosphorylation site S46 on cell structure. 
 We hypothesize that CaMKII-dependent phosphorylation of TREK-1 regulates 
cellular remodeling. In order to test this hypothesis, we mutated Ser at 46 position to Ala 
(S46A). Wildtype and mutant (Ser46Ala) TREK-1 were transfected into HEK cells and 
various properties of cell structure (percentage of cells with protrusion, number of 
protrusions, cell circumference, cell 2D-surface area, and the circumference to 2D-
surface area ratio) were analyzed. 
 
1.3 Significance  
 This study addresses an important question of how TREK-1 and posttranslational 
modification of TREK-1 via CaMKII modulates cell structure. There is currently a large 
gap in our understanding of how TREK-1 interacts with actin and how this interaction 
affects organisms at the cellular, tissue, and organ levels. Specifically, this research 
could shed new light on myocardial diseases like such as hypertrophy, arrhythmias, and 
heart failure. Linking CaMKII to TREK-1 and cellular structural changes would help 
further our understanding of CaMKII in these cardiac diseases and potentially lead to 
novel therapies. Additionally this research could help us better understand TREK-1’s 
roles in the biological response to anesthesia, neuroprotection, sensitivity to pain and 
temperature, depression, epilepsy, and architecture of the anterior eye chamber.    
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2. Methods and Materials   
 
2.1 Cloning 
KCNK2 gene (TREK-1) was purchased from commercial vendor (Open 
Biosystems) and engineered into the pIRES vector (Invitrogen). Putative CaMKII binding 
sites were identified by screening the amino acid sequence of TREK-1 for the 4-amino 
acid CaMKII binding motif Arg-x-x-Ser/Thr. Forward and reverse primers (Integrated 
DNA Technologies) for each of the putative phosphorylation sites were designed to 
mutate the serine residues to alanine residues. Site-directed mutagenesis was 
performed using QuikChange II (Agilent) and constructs were confirmed by sequencing. 
 
2.2 Western Blot Analysis 
Wild type TREK-1 and TREK-1 mutants were transfected into HEK cells and the 
cell lysates (protein concentration normalized by standard BCA protocols) were analysed 
by SDS—Page and immunoblotting. Small differences in protein loading were corrected 
using normalization with GAPDH. The following anitbodies were used for immunoblotting 
and/or immunostaining: TREK-1 (Santa Cruz)(reference 21 for b4 paper) and GAPDH 
(Fitzgerald).  
 
2.3 Phosphorylation Assay   
 PCR primers were designed to TOPO-clone the N-terminal, M2-M3 Linker, and 
C-terminal regions of TREK-1 based on a sequence obtained from GeneBank. To 
generate constructs for GST- fusion protein expression and the phosphorylation assay, 
cDNAs were were engineered in-frame into pGEX6P1 (GE Healthcare). Vectors were 
completely sequenced to confirm the sequence identity. Bacterial cells expressing the 
GST-fusion constructs were lysed in the presence of GST-beads. Activated CaMKII (10 
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μL) and the GST-beads with bound GST-TREK-1 fusion proteins were incubated for 15 
minutes in a reaction solution (30 μL tris binding buffer, 80 μg CaM, 10 μL of 20 mM 
CaCl2, 2 μL p32 ATP, and 10 μL MgCl/ATP). The solution was washed thoroughly six 
times using wash buffer (1X  PBS and 5 mM EDTA) and analyzed on a gel and 
subjected to radiography. 
 
2.4 Mammalian Cell Culture 
HEK and COS M6 cells were cultured in a growth medium (Dulbecco’s Modified 
Eagle Medium (Gibco), 10% PBS, 1%Penicillin, 1%Streptomyocin). For western blot 
analysis, HEK cells were plated at 50% confluency and allowed to grow for 48 hours 
after transfection using a Quiagen transfection kit.  
 
2.5 Immunostaining and Confocal Microscopy  
 For imaging, COS M6 cells were plated on MatTek slides at 25% confluence and 
allowed to grow for 24 hours before cell transfection. Transfection was accomplished by 
using a Quiagen transfection kit. Cells were allowed to grow for 24 hours after 
transfection and were fixed in 2% PFA. Cells were blocked in a PBS blocking buffer ( 
0.15% Triton X-100 and 3% BSA) and incubated in primary antibody for 2 hours at room 
temperature. Cells were washed 5X with blocking buffer and then incubated in 
secondary antibody (Alexa-Fluor-568) for 2 hours at room temperature. Cells were 
washed with blocking buffer 5X and mounted using Vectashield with DAPI (Vector). 
Images were collected on a Zeiss 780 confocal microscope [objective W Plan 
Apochromat 40X/1.0 DIC (Zeiss), pinhole equals 1.0 Airy Disc] using the Carl Zeiss 
Imaging software. 
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2.6 ImageJ Analysis 
 Images obtained through confocal microscopy were analyzed using ImageJ 
software to define the circumference and 2D-area of the cells. The Bioformats plug-in for 
ImageJ (Open Microscopy Environment) was used to open and analyze images. The 
default over/under threshold was adjusted until the cell boundaries were within the limits. 
The area within the boundary and circumference of the boundary were calculated by the 
ImageJ software. 
 
2.7 Statistical Analysis 
 P-values were determined for comparison using unpaired Student’s t-tests (two-
tailed). P values were considered statistically significant if P<.05. Values are expressed 
as means±SEM. 
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3. Results     
 
3.1 Phosphorylation Analysis of TREK-1 Mutant Library 
 In order to study the effect of TREK-1 posttranslational modifications on actin 
cytoskeleton, a library of TREK-1 mutants was created by mutating putative CaMKII 
phosphorylation sites (sites with amino acid sequence: Arg-X-X-Ser/Thr) in TREK-1 gene. 
Seven putative CaMKII binding sites in the TREK-1 gene (Ser 46, Ser 221, Ser 311, Ser 
344, Ser 356, Ser 362, Ser 381) were identified and the Ser amino acids in these positions 
were mutated to Ala to prevent the phosphorylation by CaMKII. (Figure 1). These 
mutations were confirmed through DNA sequencing and their protein expression was 
confirmed through Western Blot Analysis (Figure 3). TREK-1 fragments corresponding to 
the major intracellular domains [N-terminus (AA 1-115 with one putative site), M2-M3 
linker (AA 190-229),  and C-terminus (AA 305-422)] were generated as GST fusion 
proteins and used for in vitro CaMKII phosphorylation assay as described in section 2.3. 
The results of the phosphorylation assay indicate that CaMKII phosphorylates the N-
terminal region of TREK-1, where the Ser46 putative site is located (Figure 3).  
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3.2 TREK-1 expression promotes membrane projections 
 The identification of the TREK-1 N-terminus as a target for CaMKII 
phosphorylation led us to test the role of the S46 site in cytoskeletal reorganization. 
Untransfected COS M6 cells along with COS M6 cells transfected with WT and S46A 
mutant TREK-1 were imaged with confocal microscopy (Figure 4). In general, it is 
observed that both WT and mutant TREK-1 induce morphological changes in the cell 
structure. TREK-1 appears to be localized throughout the cell membrane but is 
concentrated in the filopodia-like protrusions. Although these protrusions were observed 
in all three cell types, they were more frequently observed in cells expressing WT TREK, 
than in un-transfected cells. Cells expressing S46A TREK-1 showed greater tendency to 
display protrusions than un-transfected cells, but the percentage of cells which displayed 
protrusions was smaller in number compared to cells with WT TREK (Figure 5). Along 
with the percentage of cells that exhibited filopodia-like protrusions, the number of 
protrusions per cell was used to distinguish the role of TREK in the production of these 
protrusions. A similar trend is observed for the number of protrusions per cell, where the 
Figure 3:  :  (A) Western blot showing TREK-1 expression in HEK cells that were 
transfected with WT TREK-1, untransfected, and transfected with S46A mutant 
TREK-1. (B) CaMKII phosphorylation assay on intracellular domains of TREK-1.  
Asterisks indicate location of M2-M3 and C-terminus purified proteins. 
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expression of WT TREK-1 appears to increase the number of protrusions per cell in 
comparison with untransfected cells. S46A TREK expressing cells have greater 
protrusions per cell than untransfected cells, but exhibit fewer protrusions on average 
than cells with WT TREK (Figure 6).  
 
 
 
Figure 4: (A) Untransfected COS M6 cells were stained with Di-8 ANEPPS (green). 
COS M6 cells were transfected with (B) GFP-expressing WT and (C) S46A 
constructs  immunostained for TREK-1 (red) and nuclei were stained DAPI (blue).  
Arrows represent identified projections mapped using ImageJ. The third column 
indicates the areas and circumferences found using ImageJ software. 
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Figure 5: Percentage of cells with significant projections for 
untransfected, wild type (WT) and S46A mutant transfected 
COS M6 cells. 
Figure 6: Number of projections for untransfected, wild type (WT) 
and S46A mutant transfected COS M6 cells.  P=NS. 
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3.3 S46A expressing cells have altered size 
 The untransfected, WT, and mutant TREK-1 cell images were analyzed with 
ImageJ software to determine the circumference of the monolayer of cells and their 2D-
area. Interestingly, it was observed that S46A mutant cells were significantly smaller 
than both, un-transfected cells and cells expressing WT TREK-1. The circumference of 
the untransfected and WT cells were nearly identical, while the circumference of the 
S46A mutants was about 65% of the other two groups (Figure 7). Analysis of 2D-area 
shows that the WT TREK-1 cells were smaller than the untransfected cells, however, the 
S46A mutants were significantly smaller than either of the other to two groups. These 
two findings indicate that a lack of phosphorylation at this site seems to induce a 
decrease in cell size. 
 
 
 
 
 
 
 
Figure 7: Circumference of  untransfected, wild type (WT) and 
S46A mutant transfected COS M6 cells. P=0.0024  
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3.4 TREK-1 modifies cell shape 
 In addition to the protrusions in the cell membrane and cell size, the overall cell 
shape was also analyzed. This was accomplished by finding the ratio of the 
circumference of the cell to its 2D-area. It would be expected that as the number and 
length of membrane protrusions increase in a cell, the ratio of these two values would 
increase. Additionally, as the cell shape deviates from a perfect circle, the ratio will go up 
as well.  
 The ratio of the circumference to 2D-area was smaller for untransfected 
cells than that for cells expressing WT or mutant TREK-1 (figure X). This indicates that 
untransfected cells may have a more normal membrane shape than cells expressing WT 
and mutant forms of TREK-1. Additionally, the fact that the WT and S46A mutant TREK-
1 circumference to 2D-area ratios are nearly identical suggests that although the S46A 
mutant TREK-1 cells may be smaller, they have a similar cell shape to that of WT TREK-
1. 
 
Figure 8: 2D-area of untransfected, wild type (WT) and S46A 
mutant transfected COS M6 cells. P= 0.0029 
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Figure 9: Circumference normalized to the area of cell for 
untransfected, wild type (WT) and S46A mutant transfected COS 
M6 cells. P=0.021 between Un and S46A 
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4. Discussion     
 
 Previously, it was reported that CaMKII and TREK-1 were identified as 
constituents of macromolecular complexes with βIV-spectrin and were reported to play a 
role in cytoskeleton organization. However, this is the first study to investigate 
phosphorylation of TREK-1 by CaMKII. The results of the phosphorylation assay indicate 
that CaMKII phosphorylates TREK-1 in the N-terminus region of the protein. This finding 
coupled with the preliminary screening of putative CaMKII phosphorylation sites on 
TREK-1 strongly suggest that phosphorylation occurs at Ser46. However, it would be 
interesting to analyze the in vivo phosphorylation patterns of TREK-1 using Mass 
Spectrometry (MS) methods, to both validate the current findings and discover any non-
putative phosphorylation sites in TREK-1. 
  Cell shape, size and structure are dependent upon a large number of factors. 
Previous studies have shown that TREK-1 induces filopodia-like protrusions in the cell 
membrane through interaction with actin; however, much is still unknown about how 
TREK-1 alters the cell membrane and how this morphological change affects the 
properties and functions of cells. To test the role of TREK-1 and phosphorylation of Ser 
46 on cell structure, cells transfected with WT and mutant TREK-1 were analyzed using 
confocal microscopy. The results of these tests showed that a higher percentage of cells 
expressing WT TREK exhibited filopodia-like protrusions than that of un-transfected cells 
or cells expressing TREK-1 with S46A mutation. Cells expressing mutant TREK-1 had a 
slightly higher percentage of cells exhibiting protrusions than untransfected cells. This 
trend is also seen in the number of protrusions per cell. This finding reinforces previous 
studies that have shown the percentage of cells with protrusions increases when TREK-
1 is expressed.   
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 The fact that the percentage of cells with protrusions and number of protrusions 
per cell for S46A mutant TREK-1 was between that of untransfected and cells producing 
WT TREK-1suggests that the Ser46 site just be one of the factors playing a role in 
TREK-1’s regulation of actin. It was previously shown that the interaction between these 
two proteins requires phosphorylation at Ser346 and the Glu317 proton sensor in order 
to elicit actin reorganization, but it is likely that other sites on TREK-1, such as Ser46, 
also contribute towards TREK-1 induced actin reorganization.  
 Analysis of the effects WT and mutant TREK-1 have on cell size indicate that 
Ser46 plays a role in regulating cell size. Both circumference and 2D-area of cells 
expressing S46A TREK-1 were statistically smaller than that of untransfected cells and 
cells with WT TREK-1. This combined with the finding that both WT and mutant TREK-1 
had similar ratios of circumference to 2D-area suggests that the Ser46 site modulates 
cell size without having a large impact on the overall cell shape.  
 These findings are significant because this is the first time that CaMKII has been 
shown to phosphorylate TREK-1.  Understanding the roles of CaMKII is important, 
especially for understanding cardiac disease where TREK-1 has been shown to be an 
important ion channel and CaMKII has been linked to diseases such as arrhythmias, 
hypertrophy, and heart failure. Additionally this research provides further insight into how 
TREK-1 affects cell structure. TREK-1 mediated actin reorganization could have large 
effects on the mechanical properties of the cell which in turn could alter TREK-1 current 
since it is a mechano-sensitive channel. Changes to cell mechanical properties and cell 
membrane excitability can have large ramifications on cell function at both the cellular 
and organ level. In cardiomyocytes these changes could alter action potential 
propagation and cardiac contraction leading to pathologies like arrhythmias or heart 
failure.   
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Future research into the mechanism of CaMKII phosphorylation of TREK-1 could 
use S46A mutant N-terminal TREK for a phosphorylation assay to see if this inhibits 
phosphorylation, thus pinpointing the exact amino acid of phosphorylation. Additionally, 
to determine if phosphorylation occurs in vivo, mass spectroscopy or phosphor-specific 
antibodies could be used to compare phosphorylation levels in TREK-1 between WT 
cells and cells given a CaMKII inhibitor. Additionally, overexpression of TREK-1 could be 
induced in cardiomyocytes to determine if actin restructuring occurs. The mechanical 
properties of cells with reorganized actin due to TREK-1 expression could also be 
studied by using FEM. 
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5. Conclusions 
      
Proper ion channel function is essential to human health. Ion channels serve as 
core constituents of well-defined macromolecular complexes that regulate cell 
membrane excitability and cell signaling pathways, which affects many different aspects 
of the cell such as cell structure and function. Importantly, ion channels are heavily 
regulated by posttranslational modification (e.g. phosphorylation, oxidation), which can 
have a wide array of effects on how ion channels behave. This research in particular 
focused on the effects of the two-pore, mechano-sensitive channel TREK-1 and 
posttranslational modification of this channel on cell structure. It was hypothesized that 
phosphorylation of TREK-1 by CaMKII would produce phenotypic changes in cell 
structure. This study used a phosphorylation assay to show a novel CaMKII 
phosphorylation site on the N-terminus of TREK-1, presumably at Ser46. Studies using 
immunofluorescent confocal microscopy to examine the shape and size of untransfected 
cells, cells expressing TREK-1, and cells expressing S46A found that the production of 
filopodia-like protrusions was slightly upregulated in S46A cells and was largely 
upregulated in WT TREK-1 expressing cells. These studies also showed that cells 
expressing the mutant TREK-1 were significantly smaller than both cells without TREK-1 
and with WT TREK-1. Lastly, these studies found that although the S46A cells were 
smaller, they exhibited an overall cell shape similar to that of cells producing WT TREK, 
which was significantly different from that of the untransfected cells. This research 
increases our knowledge of how proper cell structure is achieved. These studies also 
increase our understanding of the roles of TREK-1 and CaMKII at the cellular level and 
could help us better understand how diseases linked to TREK-1 and CaMKII such as 
hypertrophy, depression, arrhythmia, and heart failure. 
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